These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4850769)

  • 21. The developability classification system: application of biopharmaceutics concepts to formulation development.
    Butler JM; Dressman JB
    J Pharm Sci; 2010 Dec; 99(12):4940-54. PubMed ID: 20821390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calculation of the dissolution velocity in systems without fluid recirculation or accumulating reservoir].
    Llabrés M; Pacheco RM; Vila JL
    Farmaco Prat; 1978 Mar; 33(3):111-8. PubMed ID: 639970
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: Bioavailability of erythromycin.
    Bell SH; Smith DD
    Med J Aust; 1973 Aug; 2(8):407-8. PubMed ID: 4749538
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Bioavailability, bioequivalence and bias.
    Leopold IH
    Am J Ophthalmol; 1975 Mar; 79(3):518. PubMed ID: 1122003
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral biopharmaceutics-current status and identified gaps of understanding.
    Lennernäs H; Abrahamsson P; Langguth B
    Eur J Pharm Sci; 2014 Jun; 57():98. PubMed ID: 24508580
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Mechanisms of drug absorption and of drug solution.
    Jollow DJ
    Rev Can Biol; 1973; 32():Suppl:7-19. PubMed ID: 4777606
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: Bioavailability versus pharmacologic availability.
    Levy G
    Rev Can Biol; 1973; 32():Suppl:123. PubMed ID: 4777592
    [No Abstract]   [Full Text] [Related]  

  • 28. Excretion of drugs in human milk.
    O'Brien TE
    Am J Hosp Pharm; 1974 Sep; 31(9):844-54. PubMed ID: 4608122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biopharmaceutical properties of drugs and their bioavailability].
    Wislicki L
    Harefuah; 1975 Mar; 88(6):293-4. PubMed ID: 1132834
    [No Abstract]   [Full Text] [Related]  

  • 31. What you need to know about bioavailability.
    DiPalma JR
    RN; 1975 Sep; 38(9):114, 116, 118. PubMed ID: 1041432
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drugs and the organism (V). Biopharmaceutic models and in vivo/in vitro correlation].
    Pflegel P
    Pharmazie; 1983 Oct; 38(10):671-8. PubMed ID: 6657736
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioavailability of drugs (second of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: The line-up on bioavailability.
    Schneller GH
    Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
    [No Abstract]   [Full Text] [Related]  

  • 35. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 36. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
    Akers MJ
    Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Metabolic factors influencing bioavailability.
    Conney AH
    Rev Can Biol; 1973; 32():Suppl:163-70. PubMed ID: 4777600
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioavailability of drugs (first of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
    [No Abstract]   [Full Text] [Related]  

  • 39. Some factors affecting bioavailability of drug products.
    Lach JL
    J Iowa Med Soc; 1972 Aug; 62(8):441-2 passim. PubMed ID: 5044776
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of route of administration on drug disposition.
    Riegelman S; Rowland M
    J Pharmacokinet Biopharm; 1973 Oct; 1(5):419-34. PubMed ID: 4787618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.